LBPH (longboardpharma.com) Quarterly Sales Growth

Symbol and logo of brand Longboard Pharmaceuticals (LBPH)

Focusing on the domestic US market minimizes trade war risks for Longboard Pharmaceuticals. However, a global shortage of electronic components may complicate the logistics of medical developments. The quarterly revenue growth rate demonstrates the current resilience of the business, where the 0.00 mark records this metric. An innovative approach to GPCR receptors in the treatment of epilepsy paves the way for the company to dominate the high-cost neuromedicine segment.

LBPH Longboard Pharmaceuticals Inc Revenue Dynamics QoQ (07/04/2022 - 12/07/2024)

Summary analytical data breakdowns for Longboard Pharmaceuticals Inc (LBPH)

- cash and cash flow data:
General company analysis:LBPH - longboardpharma.com
Manufactured products of Longboard Pharmaceuticals, Inc.

The effective coordination of temperature-controlled supply chains for neurological molecules and the diversification of warehouses at Longboard Pharmaceuticals (LBPH) directly determine the scaling pace of its commercial operations. By analyzing quarterly revenue dynamics, an investor assesses the speed of business expansion, where sustained acceleration confirms market share growth, although purchasing an asset at the peak of its development rate carries the risk of capital drawdown during a phase shift.

Competitor analysis

BIIB - Revenue Growth QoQ|NBIX (Neurocrine Biosciences) - Sales Growth QoQ|RGC: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Axsome (AXSM)|Revenue Growth QoQ ACADIA Pharmaceuticals Inc|Quarterly Sales Growth Xenon Pharmaceuticals Inc (XENE)|Quarterly Revenue Growth VKTX|Quarterly Revenue Growth supernus.com (SUPN)|Revenue Growth QoQ Catalyst Pharmaceuticals, Inc. CPRX|DNLI (Denali Therapeutics Inc.) - Revenue Dynamics QoQ|Harmony Corp - Quarterly Revenue Growth|BHVN: Revenue Growth QoQ|AMLX: Quarterly Revenue Growth|TRVI: Sales Change QoQ|Revenue Growth QoQ Praxis Medicines|Quarterly Revenue Growth Rate Anavex AVXL|Revenue Growth QoQ CeriBell Corp (CBLL)|Sales Change QoQ PRTA|Quarterly Revenue Growth ALEC (Alector)|Annexon (ANNX) - Quarterly Revenue Growth Rate|OMER - Revenue Growth QoQ|NGNE (Neurogene) - Sales Growth QoQ|ACIU: Quarterly Revenue Growth|VYGR - Quarterly Sales Growth Rate|Revenue Growth QoQ Neumora Therapeutics, Inc.|Sales Growth QoQ SCLX (Scilex)|Quarterly Sales Growth TVGN (Tevogen Bio)|Quarterly Revenue Growth Alpha Cognition Inc (ACOG)|Quarterly Revenue Growth CGTX (cogrx.com)|Quarterly Sales Growth Rate Inhibikase Pharma (IKT)|SAVA: Quarterly Sales Growth|Quarterly Sales Growth Rate Assertio ASRT|COYA (coyatherapeutics.com) - Quarterly Sales Growth|Sales Growth QoQ VTGN|OVID (Ovid Therapeutics) - Quarterly Revenue Growth|Acumen Pharmaceuticals, Inc (ABOS) - Quarterly Sales Growth Rate|Revenue Growth QoQ CervoMed, Inc. (CRVO)|ATHE - Quarterly Revenue Growth Rate|Quarterly Revenue Growth CLNN (Clene Inc.)|Quarterly Sales Growth Rate PepGen Inc. (PEPG)|JUNS - Revenue Growth QoQ|Quarterly Revenue Growth Rate Relmada Corp|ANVS (Annovis Bio, Inc.) - Quarterly Sales Growth|Grace Tx (GRCE) - Quarterly Revenue Growth|Quarterly Sales Growth AIFF|Quarterly Revenue Growth anewmeds.com|Revenue Growth QoQ NeuroSense Therapeutics (NRSN)|RVPH (Reviva Pharmaceuticals Holdings) - Quarterly Revenue Increase|MetaVia - Quarterly Sales Growth|NRXS: Sales Growth QoQ|Helius Medical Technologies, Inc. - Quarterly Revenue Growth|PASG: Revenue Growth QoQ|Neuphoria (NEUP) - Revenue Growth QoQ|Minerva Neurosciences - Quarterly Revenue Increase|ATHA (Athira Pharma, Inc.) - Quarterly Revenue Growth|Quarterly Revenue Growth Rate addextherapeutics.com ADXN|Quarterly Sales Growth ALZN (Alzamend Neuro Inc.)|CYCN (Cyclerion Therapeutics, Inc.) - Quarterly Revenue Increase|Quarterly Revenue Growth PTIX (Protagenic)|Quarterly Revenue Growth pasitheaclinics.com KTTA|CRGT - Revenue Growth QoQ|Quarterly Revenue Increase ATXI (Avenue Therapeutics)|BCLI: Quarterly Revenue Growth|Cara Therapeutics - Quarterly Revenue Increase|Revenue Growth QoQ Chromocell Therapeutics Corporation|Quarterly Revenue Growth Eliem Therapeutics Inc.|Revenue Growth QoQ Intra-Cellular Therapies, Inc. (ITCI)|MRNS (Marinus Pharmaceuticals) - Quarterly Revenue Increase|Revenue Growth QoQ NKGen NKGN|Quarterly Revenue Growth NeuroBo Pharmaceuticals Inc NRBO|SAGE: Quarterly Sales Growth|Quarterly Sales Growth Rate Synaptogenix, Inc SNPX|TRVN: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Vigil Neuroscience (VIGL)|Revenue Growth QoQ Anew Medical, Inc.|CERE (Cerevel Therapeutics, Inc.) - Sales Change QoQ